HIGHLIGHTS
THIS YEAR
-
TISSUE-SPECIFIC
microRNA DIAGNOSTIC MARKERS
-
NON
CODING RNAs IN CANCER PREDISPOSITION AND
TUMOR DEVELOPMENT
-
microRNAs
IN CHRONIC MYELOID LEUKEMIA
-
RESPONSE
PREDICTION IN ONCOLOGY
-
TOXICOLOGY
STRATEGY SPECIFIC TO
-
NOVEL
ONCOLOGY TARGETS
-
MOLECULAR
MARKERS OF PROSTATE CANCER STEM CELLS
-
POTENTIAL
FOR IN SITU PROXIMITY
LIGATION DIAGNOSTICS
 |
|
Regulation
of Diagnostic Tests
Steven I. Gutman, M.D., Director, Office of In Vitro Diagnostic Device Evaluation and Safety, Food & Drug Administration
- Speaker Biography
|
FEATURED SPEAKERS
Andrea Califano, Ph.D., Professor and
Director, Genome Center Bioinformatics, Columbia University
Pablo Landgraf, M.D., Ph.D., Group
Leader, Department of Pediatric Oncology, Hematology and Clinical
Immunology, Childrens Hospital of the Heinrich-Heine University Dsseldorf
George A. Calin, M.D., Ph.D., Associate
Professor, Department of Experimental Therapeutics, University of Texas, MD
Anderson Cancer Centre
Isidore Rigoutsos, Ph.D., Manager,
Bioinformatics & Pattern Discovery Group, Computational Biology Center,
IBM Thomas J. Watson Research Center
John Bartlett, Ph.D., Group Leader,
Endocrine Cancer Group, University of Edinburgh Cancer Research Centre
Holly K. Dressman, Ph.D., Associate
Research Professor, Director, Duke Microarray Facility
Japanese
Korean
English